Cargando…

Metabolic reprogramming of myeloid-derived suppressive cells

Detalles Bibliográficos
Autores principales:	Du, Hong, Ding, Xinchun, Yan, Cong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5441473/ https://www.ncbi.nlm.nih.gov/pubmed/28540333 http://dx.doi.org/10.18632/oncoscience.349

Ejemplares similares

Establishment of lal-/- Myeloid Lineage Cell Line That Resembles Myeloid-Derived Suppressive Cells
por: Ding, Xinchun, et al.
Publicado: (2015)

Rab7 GTPase controls lipid metabolic signaling in myeloid-derived suppressor cells
por: Ding, Xinchun, et al.
Publicado: (2017)

Gene Profile of Myeloid-Derived Suppressive Cells from the Bone Marrow of Lysosomal Acid Lipase Knock-Out Mice
por: Yan, Cong, et al.
Publicado: (2012)

Activation of mTOR Pathway in Myeloid-derived Suppressor Cells Stimulates Cancer Cell Proliferation and Metastasis in lal−/− Mice
por: Zhao, Ting, et al.
Publicado: (2014)

LAL deficiency induced myeloid-derived suppressor cells as targets and biomarkers for lung cancer
por: Zhao, Ting, et al.
Publicado: (2023)

Metabolic Reprogramming in Mitochondria of Myeloid Cells
por: Zuo, Hao, et al.
Publicado: (2019)

MicroRNA-155 regulates tumor myeloid-derived suppressive cells
por: Chen, Siqi, et al.
Publicado: (2015)

Metabolic and functional reprogramming of myeloid-derived suppressor cells and their therapeutic control in glioblastoma
por: Won, Woong-Jai, et al.
Publicado: (2019)

Metabolic reprogramming of myeloid‐derived suppressor cells: An innovative approach confronting challenges
por: Li, Xiaoqing, et al.
Publicado: (2021)

Metabolic Reprogramming in Health and Disease
por: Chiellini, Grazia
Publicado: (2020)

Metabolic Reprogramming and Vulnerabilities in Cancer
por: Lyssiotis, Costas A., et al.
Publicado: (2019)

Targeting Metabolic Reprogramming in Acute Myeloid Leukemia
por: Castro, Isabel, et al.
Publicado: (2019)

Editorial: Metabolic reprogramming and cancer progression
por: Yin, Qinan, et al.
Publicado: (2022)

Understanding metabolic reprogramming in tumor microenvironment
por: Shu, Shaokun, et al.
Publicado: (2022)

Stem Cells and Nuclear Reprogramming
por: Du, Fuliang, et al.
Publicado: (2011)

Lysosomal acid lipase, CSF1R, and PD-L1 determine functions of CD11c(+) myeloid-derived suppressor cells
por: Zhao, Ting, et al.
Publicado: (2022)

Cancer progression by reprogrammed BCAA metabolism in myeloid leukemia
por: Hattori, Ayuna, et al.
Publicado: (2017)

Circular RNA: The main regulator of energy metabolic reprogramming in cancer cells
por: Zhang, Liyi
Publicado: (2019)

Hungry for Chloride: Reprogramming Endothelial Cell Metabolism in Pulmonary Arterial Hypertension
por: Bousseau, Simon, et al.
Publicado: (2022)

Nrf2 Is a Central Regulator of Metabolic Reprogramming of Myeloid-Derived Suppressor Cells in Steady State and Sepsis
por: Ohl, Kim, et al.
Publicado: (2018)

Myeloid-Derived Suppressor Cells (MDSCs) in Haematology
por: Bizymi, Nikoleta, et al.
Publicado: (2021)

TLR8 reprograms human Treg metabolism and function
por: Liu, Xia, et al.
Publicado: (2019)

Estrogens drive myeloid-derived suppressor cell accumulation
por: Conejo-Garcia, Jose R., et al.
Publicado: (2017)

Poldip2 takes a central role in metabolic reprograming
por: Paredes, Felipe, et al.
Publicado: (2018)

Tumor Metabolome: Therapeutic Opportunities Targeting Cancer Metabolic Reprogramming
por: Márquez, Javier, et al.
Publicado: (2021)

Critical role of PPARγ in myeloid-derived suppressor cell-stimulated cancer cell proliferation and metastasis
por: Zhao, Ting, et al.
Publicado: (2015)

Reprogramming patient-derived tumor cells generates model cell lines for tuberous sclerosis-associated lymphangioleiomyomatosis
por: Julian, Lisa M., et al.
Publicado: (2017)

Immunostimulatory RNA leads to functional reprogramming of myeloid-derived suppressor cells in pancreatic cancer
por: Metzger, Philipp, et al.
Publicado: (2019)

Identification of Reprogrammed Myeloid Cell Transcriptomes in NSCLC
por: Durrans, Anna, et al.
Publicado: (2015)

Targeting chemoresistance and mitochondria-dependent metabolic reprogramming in acute myeloid leukemia
por: Feng, Lili, et al.
Publicado: (2023)

Metabolic Reprogramming of GMP Grade Cord Tissue Derived Mesenchymal Stem Cells Enhances Their Suppressive Potential in GVHD
por: Mendt, Mayela, et al.
Publicado: (2021)

Corruptive Reprograming of Macrophages into Tumor-Associated Macrophages: The Transcriptional, Epigenetic and Metabolic Basis
por: Ahmad, Aamir
Publicado: (2023)

Linking Immunoevasion and Metabolic Reprogramming in B-Cell–Derived Lymphomas
por: Böttcher, Martin, et al.
Publicado: (2020)

Correction to: Immunostimulatory RNA leads to functional reprogramming of myeloid-derived suppressor cells in pancreatic cancer
por: Metzger, Philipp, et al.
Publicado: (2019)

Antitumor effects of targeting myeloid-derived suppressive cells
por: Zeng, Dong, et al.
Publicado: (2020)

Energy metabolism manipulates the fate and function of tumour myeloid-derived suppressor cells
por: Hu, Cong, et al.
Publicado: (2019)

Why Cell Reprogramming is Functionally Linked to Aging?
por: Zhao, Jian, et al.
Publicado: (2011)

Fursultiamine Alleviates Choroidal Neovascularization by Suppressing Inflammation and Metabolic Reprogramming
por: Do, Ji Yeon, et al.
Publicado: (2020)

MYCN and Metabolic Reprogramming in Neuroblastoma
por: Bansal, Mohit, et al.
Publicado: (2022)

ATF4 Regulates CD4(+) T Cell Immune Responses through Metabolic Reprogramming
por: Yang, Xi, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_q5es0b0iie1shkgfhsq9rnceq4